Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Brussels Focuses Apple Probe On App Restrictions

Brussels Focuses Apple Probe On App Restrictions

-Financial Times https://www.ft.com/content/ca354eea-fadd-4004-ad2a-8817fec557f4

byCharles Gross

February 28, 2023

1 minute read

-Financial Times

https://www.ft.com/content/ca354eea-fadd-4004-ad2a-8817fec557f4

D.R. Horton Whale Trades For July 21

By Benzinga Insights

July 21, 1:33 PM

A whale with a lot of money to spend has taken a noticeably bullish stance on D.R. Horton. Looking at options history for D.R. Horton (NYSE:DHI) we detected 11 strange trades.

DHI

News

IBM Advances watsonx AI And Data Platform With Tech Preview For watsonx.governance And Planned Release Of New Models And Generative AI In watsonx.data

By Happy Mohamed

September 7, 8:15 AM

- Watsonx AI and data platform to include new generative AI models and enhancements designed to help enterprises scale AI - Capabilities on display for thousands of developers at IBM TechXchange

IBM

Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024

By Vandana Singh

August 5, 11:13 AM

Voyager Therapeutics Inc (NASDAQ:VYGR) unveiled its prioritized therapeutic pipeline focusing on tau antibody for Alzheimer’s disease and gene therapies for GBA1…

NVS

Raymond James Maintains Strong Buy on Kimbell Royalty Partners, Lowers Price Target to $23

By Benzinga Newsdesk

January 26, 9:19 AM

Raymond James analyst John Freeman maintains Kimbell Royalty Partners (NYSE:KRP) with a Strong Buy and lowers the price target from $26 to $23.

KRP

Brussels Focuses Apple Probe On App Restrictions

Related Posts

D.R. Horton Whale Trades For July 21

IBM Advances watsonx AI And Data Platform With Tech Preview For watsonx.governance And Planned Release Of New Models And Generative AI In watsonx.data

Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024

Raymond James Maintains Strong Buy on Kimbell Royalty Partners, Lowers Price Target to $23